Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;66(7):1332-1338.
doi: 10.1111/jgs.15385. Epub 2018 Apr 20.

Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults

Jan Zirk-Sadowski  1   2 , Jane A Masoli  1   3 , Joao Delgado  1 , Willie Hamilton  4 , W David Strain  3   5 , William Henley  6 , David Melzer  1 , Alessandro Ble  1
Affiliations

Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults

Jan Zirk-Sadowski et al. J Am Geriatr Soc. 2018 Jul.

Abstract

Objectives: To estimate associations between long-term use of proton pump inhibitors (PPIs) and pneumonia incidence in older adults in primary care.

Design: Longitudinal analyses of electronic medical records.

Setting: England PARTICIPANTS: Individuals aged 60 and older in primary care receiving PPIs for 1 year or longer (N=75,050) and age- and sex-matched controls (N=75,050).

Measurements: Net hazard ratios for pneumonia incidence in Year 2 of treatment were estimated using the prior event rate ratio (PERR), which adjusts for pneumonia incidence differences before initiation of treatment. Inverse probability weighted models adjusted for 78 demographic, disease, medication, and healthcare usage measures.

Results: During the second year after initiating treatment, PPIs were associated with greater hazard of incident pneumonia (PERR-adjusted hazard ratio=1.82, 95% confidence interval=1.27-2.54), accounting for pretreatment pneumonia rates. Estimates were similar across age and comorbidity subgroups. Similar results were also obtained from propensity score- and inverse probability-weighted models.

Conclusion: In a large cohort of older adults in primary care, PPI prescription was associated with greater risk of pneumonia in the second year of treatment. Results were robust across alternative analysis approaches. Controversies about the validity of reported short-term harms of PPIs should not divert attention from potential long-term effects of PPI prescriptions on older adults.

Keywords: pneumonia; primary care; proton pump inhibitors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence rates of community acquired pneumonia according to months before and after index date in proton pump inhibitor–treated participants and controls (N=151,952).
See this image and copyright information in PMC

Comment in

References

    1. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013;108:308–328. - PubMed
    1. National Institute for Health and Care Excellence (NICE) . Gastro‐Oesophageal Reflux Disease and Dyspepsia in Adults: Investigation and Management, 2014, https://www.nice.org.uk/guidance/cg184/chapter/1-Recommendations - PubMed
    1. Lanas A. We are using too many PPIs, and we need to stop: A European perspective. Am J Gastroenterol 2016;111:1085–1086. - PubMed
    1. Abrahamsen B, Vestergaard P. Proton pump inhibitor use and fracture risk—effect modification by histamine H1 receptor blockade. Observational case‐control study using National Prescription Data. Bone 2013;57:269–271. - PubMed
    1. Elaine WY, Bauer SR, Bain PA, Bauer DC. Proton pump inhibitors and risk of fractures: A meta‐analysis of 11 international studies. Am J Med 2011;124:519–526. - PMC - PubMed

Publication types